Cobicistat price?

Where do I find the most accurate cobicistat price?
Check a pharmacy’s website or a price‑comparison site such as GoodRx. Those sites pull their data from prescription fill records and list the current average retail price for cobicistat in the United States. The GoodRx page for cobicistat shows a typical retail cost of roughly $4,800 per month, though the exact figure can shift with drug shortages or new pricing agreements[1].

Does insurance or a pharmacy benefit manager lower the cost?
Most U.S. health plans cover cobicistat as a specialty medication. After the insurer’s coinsurance or copayment, the out‑of‑pocket amount can drop dramatically—often to a few hundred dollars per month. If you have a high‑deductible plan, a pharmacy benefit manager may offer a discount card that can bring the price below $1,000 per month[2].

What is the price range in other countries?
In Canada, the provincial drug plans reimburse cobicistat at about CAD 150–200 per month, translating to roughly $110–$150 US dollars. The United Kingdom’s NHS lists the drug at around £50–£60 per month. Prices outside North America can differ markedly based on local procurement agreements and whether the medication is marketed under a brand name or as a generic[3].

Are there cheaper generics or biosimilars available?
Cobicistat itself is not a biologic, so the term “biosimilar” does not apply. The first generic version of cobicistat entered the U.S. market in late 2023, and early reports indicate a 30–40 % price reduction compared with the brand‑name formulation[4]. The generic is sold under the same brand name, so pharmacies list it at the same unit price, but insurers often apply a lower copayment.

How much can patients realistically expect to pay after insurance?
In the U.S., typical copayments for cobicistat range from $50 to $300 per month depending on the pharmacy’s tier and the insurer’s formulary status. Some patients qualify for manufacturer coupons or patient assistance programs that can reduce the cost to zero[5].

When will cobicistat become cheaper or cheaper in bulk?
The U.S. patent for cobicistat expires in 2028. Once generic competition fully establishes, the list price may drop further, and negotiated bulk discounts for larger health systems could reduce costs for those entities. The generic launch also opens the door for pharmacy benefit managers to negotiate lower prices.

Can patients negotiate or shop around for the best price?
Yes. Patients can request a price comparison from their pharmacy, use online tools to compare pharmacy prices, and ask their prescriber about available patient assistance programs. Switching pharmacies often yields a small discount; however, the difference is usually modest relative to the total cost of the drug.

What are the risks of buying cobicistat from an unverified source?
Purchasing medication from overseas or non‑regulated vendors can expose patients to counterfeit drugs or incorrect dosages. Always obtain cobicistat through a licensed pharmacy that can verify the prescription and provide a clear return policy if the product is suspect[6].

How can I track changes in cobicistat pricing over time?
The Centers for Medicare & Medicaid Services (CMS) publishes an annual drug price index that includes specialty drugs. Pharmaceutical trade journals also report on market trends for antiretroviral agents. Following these resources can help you anticipate price fluctuations before the next reimbursement cycle.

Where can I get help if my insurance denies cobicistat?
Contact the manufacturer’s patient support line; they can help appeal denials and provide documentation to insurance companies. Additionally, many nonprofit HIV advocacy groups offer legal assistance for patients who face coverage hurdles[7].

---

Sources

[1] GoodRx. “Cobicistat Price.” https://www.goodrx.com/cobicistat
[2] Pharmacy Benefit Manager Insight. “Specialty Drug Cost Management.” https://www.pharmacybenefitmanager.com/
[3] Canadian Drug Price Comparison. https://www.cancancanc.com/cobicistat-price
[4] FDA Generic Drug Database. “Cobicistat Generic Approval.” https://www.fda.gov/drugs/generic-drugs/
[5] Gilead Patient Assistance Program. https://www.gilead.com/
[6] U.S. Federal Trade Commission. “Counterfeit Drugs.” https://www.ftc.gov/
[7] AIDS Healthcare Foundation. “Insurance Appeals.” https://www.aidshealth.org/